BLOG.FRANKMS.COM: Category Archive for MS Research

Patients to bear the burden?

From the National Multiple Sclerosis Society

Fast Forward LLC,

Google MS News 3/3

New Research

Promising Stem Cell Therapy

ASCEND SP MS TRIAL

Find Offers Hope...

The Year in Neurology: Studies Not to Miss From 2011: Multiple Sclerosis

Teens who work nights have 'double risk of MS'

Multiple Sclerosis Research Shows It’s Not Tied to Narrow Blood

57 Genes Now Linked to MS

Analysis: Why in an age of health cuts we need more government research

Progress in Managing MS Symptoms and Other Results Reported at CMSC Annual Meeting

MS Trial Alert: Recruiting for a Nationwide Study of an Investigational New Treatment for Spasticity

Research Teams Report First Year’s Progress From MS Societies’ Initial Studies on CCSVI and MS

Shingles May be Related to Multiple Sclerosis

CMSC: Rogue Enzyme Implicated in MS

CMSC: Retinal Scans Eyed for Tracking MS

CMSC: MiRNAs Dubbed Biomarkers, Tx Targets in MS

Fostering a Team Approach to Drug Cures

Helping New Drugs Out of Research’s ‘Valley of Death’

Neutralising cytokine GM-CSF can halt multiple sclerosis: Study

T Cells

CDMRP Grants

2010: A Year of Significant Progress in MS Research

Key Player in Nervous System Repair Identified

UCI immunological study finds earlier way to diagnose MS

Potential new Multiple Sclerosis Treatment

False hope and cold reality

Outlandish Opinion

Over $2.4 Million Committed to Support 7 Initial CCSVI Grants to Determine the Role of CCSVI (Venous Insufficiency) in MS Disease Process

Settling the nerves

Environment Plays Major Role in Development of Multiple Sclerosis

Catching multiple sclerosis before it strikes

Novartis Investigational Multiple Sclerosis Therapy Gilenia* (FTY720) Shown To Reduce Relapse Rates Regardless Of Treatment History

Study Fuels Progress Toward Predicting An Individual’s Response to MS Therapy

First Blinded Study of Venous Insufficiency Prevalence in Multiple Sclerosis Shows Promising Results

CCSVI or Blood Flow in the Brain and Venous Insufficiency in Multiple Sclerosis

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Amazing Multiple Sclerosis Research for 2010

Possible MS Breakthrough Neglected By American Media

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity

Calendar

Category Archives

Recent Posts

  1. ASK...
    Wednesday, May 30, 2012
  2. Arthritis Foundation, Great Lakes
    Wednesday, May 30, 2012
  3. Friends
    Tuesday, May 29, 2012
  4. Change
    Tuesday, May 29, 2012
  5. HELANTISUBRON 7 (HS-7)
    Monday, May 28, 2012
  6. HC-7, The Legacy
    Monday, May 28, 2012
  7. TAPS
    Sunday, May 27, 2012
  8. Louisville, KY
    Sunday, May 27, 2012
  9. Clyde Lassen
    Saturday, May 26, 2012
  10. Michael Patrick Murphy
    Saturday, May 26, 2012

Recent Comments

  1. Doris on PCIP Changes
    5/10/2012
  2. Shirley on Ticketed
    5/6/2012
  3. Frank on Losing ACCESS Service
    4/30/2012
  4. Shirley on Losing ACCESS Service
    4/30/2012
  5. Frank on Losing ACCESS Service
    4/30/2012
  6. Sherie on Losing ACCESS Service
    4/30/2012
  7. Treatments for PML on Gilenya, Tysabri & PML
    4/19/2012
  8. Shirley on Guide Dog Meets Pluto
    3/12/2012
  9. Shirley on Fresno Hit and Split
    3/3/2012
  10. Shirley on 77 Year Old Driver Charged
    2/19/2012

Subscribe


Tag Cloud

Blog Software